An interventional study of Transanal decompression tube and Stent in Colonic Cancer and Rectal Cancer, sponsored by Xuzhou Central Hospital. Terminated at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-07-05.
Sponsored by Xuzhou Central Hospital · Not applicable, Interventional, and Treatment
The purpose of this study is to compare the clinical outcomes of transanal decompression tube as a bridge to surgery with stent as a bridge to surgery for acute malignant left-sided colonic and rectal obstruction.
Approximately 8-47 % of patients with colorectal cancer will present with colonic obstruction. Left-sided colonic and rectal cancer is responsible for nearly 70% of acute colonic obstruction. Emergency colonic surgery for acute obstruction is associated with a higher mortality and morbidity rate than elective surgery. Preoperative decompression results in a less dilated bowel that is more amenable to an elective surgery. Both transanal decompression tube and stent can serve a good preoperative decompression effect and serve a good bridge to surgery. Investigators aim to compare the clinical outcomes of transanal decompression tube as a bridge to surgery with stent as a bridge to surgery for acute malignant left-sided colonic and rectal obstruction.
1,485 studies on the registry are indexed under Colonic Neoplasms; 362 are open to participants now.
This study's enrollment of 8 is below the median of 89 across 1,067 interventional studies indexed under Colonic Neoplasms.
Browse Colonic Neoplasms studies →Xuzhou Central Hospital is the lead sponsor of 21 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients undergo placement of the transanal decompression tube as a bridge to surgery
Device: Transanal decompression tube
Patients undergo placement of the stent as a bridge to surgery
Device: Stent
22 Fr transanal decompression tube
self-expandable colorectal nitinol alloys stent
Creation of stoma
Creation of stoma include temporary and definitive stoma.
Time frame: From the date of randomization until the date of first documented creation of stoma, assessed up to 24 months
Transanal decompression tube/stent-related complications
Transanal decompression tube/stent-related complications usually include bowel perforation, migration, and stent re-obstruction.
Time frame: From the date of randomization until the date of first documented transanal decompression tube/stent-related complication, assessed up to 7 days
Surgery-related complications
Surgery-related complications usually include wound complications and anastomotic leak.
Time frame: From the date of randomization until the date of first documented surgery-related complication, assessed up to 24 months
Overall survival
Time frame: From the date of randomization until the date of death from any cause, assessed up to 24 months
Plan to share: No
Ran from Oct 2015 to primary completion in Jun 2016, 8 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Xuzhou Central Hospital